Pines Wealth Management’s Boston Scientific BSX Stock Holding History

Pines Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$512K	Buy	11,734 +1,691	+17%	+$78.3K	0.15%	128
2026 Q2	$429K	Buy	10,043 +2,136	+27%	+$116K	0.12%	150
2026 Q1	$496K	Sell	7,907 -530	-6%	-$42.4K	0.16%	129
2025 Q4	$804K	Sell	8,437 -398	-5%	-$39K	0.26%	94
2025 Q3	$863K	Sell	8,835 -224	-2%	-$23.2K	0.29%	88
2025 Q2	$945K	Buy	9,059 +674	+8%	+$68.2K	0.33%	77
2025 Q1	$760K	Sell	8,385 -28	-0.3%	-$2.82K	0.35%	73
2024 Q4	$798K	Buy	+8,413	New	+$741K	0.35%	71

Other funds holding BSX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Pines Wealth Management's BSX Position: Q3 2026 in Review

Pines Wealth Management increased its Boston Scientific (BSX) stake by 17% in Q3 2026, buying an estimated $78.3K and bringing the position to 11,734 shares worth $512K. The position accounts for 0.15% of the portfolio, ranked #128.

Pines Wealth Management first reported a position in BSX in Q4 2024 and has held it in 8 quarters since. The position peaked at $945K in Q2 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Pines Wealth Management held 11,734 shares of Boston Scientific worth $512K as of Q3 2026.
Pines Wealth Management bought 1,691 Boston Scientific shares in Q3 2026, an estimated $78.3K.
Boston Scientific made up 0.15% of Pines Wealth Management's portfolio in Q3 2026, its #128 holding.
Pines Wealth Management first reported a position in Boston Scientific in Q4 2024 and has held it in 8 quarters since.
Pines Wealth Management's Boston Scientific position peaked at $945K in Q2 2025.
1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Pines Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.